Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Alexion seeks E.U. approval for ALXN-1210 for PNH

June 28, 2018

Apellis initiates phase III trial of APL-2 in PNH

June 27, 2018

Alexion submits U.S. BLA for ALXN-1210 to treat PNH

June 19, 2018

Catalyst offers update from Cohort 6 in phase I/II trial of CB-2679d for hemophilia B

June 19, 2018

Verseon prepares for phase I study of oral anticoagulant VE-1902

June 14, 2018

MaxCyte and NIH enter CRADA for sickle cell disease

June 11, 2018

FDA approves Mircera for pediatric use

June 8, 2018

FDA grants orphan drug designation to olinciguat for sickle cell disease

June 8, 2018

Biogen enters agreement to acquire stroke drug candidate from TMS

June 8, 2018

Merck & Co. synthesizes new FXIIa inhibitors

June 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...